Acasti Pharma Inc (ACST)
2.90
-0.03
(-0.97%)
USD |
NASDAQ |
Apr 26, 16:00
2.92
+0.02
(+0.69%)
After-Hours: 20:00
Acasti Pharma Free Cash Flow (Quarterly): -1.892M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.892M |
| September 30, 2023 | -2.113M |
| June 30, 2023 | -6.24M |
| March 31, 2023 | -3.334M |
| December 31, 2022 | -3.722M |
| September 30, 2022 | -3.441M |
| June 30, 2022 | -5.433M |
| March 31, 2022 | -3.145M |
| December 31, 2021 | -4.584M |
| September 30, 2021 | -6.104M |
| June 30, 2021 | -3.401M |
| March 31, 2021 | -1.76M |
| December 31, 2020 | -4.214M |
| September 30, 2020 | -4.209M |
| June 30, 2020 | -4.205M |
| March 31, 2020 | -2.931M |
| December 31, 2019 | -7.361M |
| September 30, 2019 | -6.135M |
| June 30, 2019 | -6.843M |
| March 31, 2019 | -8.527M |
| December 31, 2018 | -6.946M |
| September 30, 2018 | -5.349M |
| June 30, 2018 | -4.499M |
| March 31, 2018 | -3.300M |
| December 31, 2017 | -3.608M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.798M |
| June 30, 2017 | -1.340M |
| November 30, 2016 | -1.796M |
| August 31, 2016 | -1.102M |
| May 31, 2016 | -1.981M |
| February 29, 2016 | -1.242M |
| November 30, 2015 | -1.287M |
| August 31, 2015 | -1.714M |
| May 31, 2015 | -0.8797M |
| February 28, 2015 | -1.761M |
| November 30, 2014 | -1.852M |
| August 31, 2014 | -1.739M |
| May 31, 2014 | -0.4696M |
| February 28, 2014 | -4.203M |
| November 30, 2013 | -0.8547M |
| August 31, 2013 | -0.2583M |
| May 31, 2013 | -0.933M |
| February 28, 2013 | 0.0557M |
| November 30, 2012 | -0.5936M |
| August 31, 2012 | -1.421M |
| May 31, 2012 | -0.6319M |
| February 29, 2012 | -1.433M |
| November 30, 2011 | -3.144M |
| August 31, 2011 | -0.6448M |
| May 31, 2011 | -0.4252M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.361M
Minimum
Dec 2019
-1.76M
Maximum
Mar 2021
-4.267M
Average
-4.205M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6766M |
| Xenon Pharmaceuticals Inc | -35.54M |
| ESSA Pharma Inc | -6.787M |